Where I see patients (1)
My reviews
Selected research
-
Wearables for the Bladder: Stakeholder Perspectives on Moving Multiple Sclerosis Bladder Dysfunction Interventions Into the 21st Century.
International journal of MS care
-
Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Nature reviews. Neurology
-
Topical review: Lactation and use of DMTs in women with MS.
Multiple sclerosis (Houndmills, Basingstoke, England)
Clinical trials
VIRtual Versus UsuAL In-office Care for Multiple Sclerosis (VIRTUAL-MS)
The primary outcome will be disability worsening in one of the Multiple Sclerosis Functional Composite components at 24 months. Worsening is defined as 20% worsening in Timed 25 foot walking speed (T25FW), 20% worsening in the 9 h...
Recruiting
Bazedoxifene Acetate as a Remyelinating Agent in Multiple Sclerosis
The primary objective is to evaluate the efficacy of BZA relative to placebo for increasing MWF on MRI within normal appearing white matter of the corpus callosum, between baseline and 90 days in a double-blinded trial (1st 90 day...
Recruiting
4.9